Theodore R. Schroeder, Chief Executive Officer at Nabriva Therapeutics plc (NBRV), bought 50,000 shares at $1.79 ($90K) on 2019-08-27, disclosed to the SEC on 2019-08-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |
| CADX | SELL | 2010-07-01 | $350K | — | Filing → |